United States Natamycin Market Report 2017

United States Natamycin Market Report 2017

1 Natamycin Overview

1.1 Product Overview and Scope of Natamycin

1.2 Classification of Natamycin by Product Category

1.2.1 United States Natamycin Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Natamycin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Natamycin 50%

1.2.4 Natamycin 95%

1.3 United States Natamycin Market by Application/End Users

1.3.1 United States Natamycin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Food Industry

1.3.3 Medical Industry

1.3.4 Other

1.4 United States Natamycin Market by Region

1.4.1 United States Natamycin Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Natamycin Status and Prospect (2012-2022)

1.4.3 Southwest Natamycin Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Natamycin Status and Prospect (2012-2022)

1.4.5 New England Natamycin Status and Prospect (2012-2022)

1.4.6 The South Natamycin Status and Prospect (2012-2022)

1.4.7 The Midwest Natamycin Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Natamycin (2012-2022)

1.5.1 United States Natamycin Sales and Growth Rate (2012-2022)

1.5.2 United States Natamycin Revenue and Growth Rate (2012-2022)

2 United States Natamycin Market Competition by Players/Suppliers

2.1 United States Natamycin Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Natamycin Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Natamycin Average Price by Players/Suppliers (2012-2017)

2.4 United States Natamycin Market Competitive Situation and Trends

2.4.1 United States Natamycin Market Concentration Rate

2.4.2 United States Natamycin Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Natamycin Manufacturing Base Distribution, Sales Area, Product Type

3 United States Natamycin Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Natamycin Sales and Market Share by Region (2012-2017)

3.2 United States Natamycin Revenue and Market Share by Region (2012-2017)

3.3 United States Natamycin Price by Region (2012-2017)

4 United States Natamycin Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Natamycin Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Natamycin Revenue and Market Share by Type (2012-2017)

4.3 United States Natamycin Price by Type (2012-2017)

4.4 United States Natamycin Sales Growth Rate by Type (2012-2017)

5 United States Natamycin Sales (Volume) by Application (2012-2017)

5.1 United States Natamycin Sales and Market Share by Application (2012-2017)

5.2 United States Natamycin Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Natamycin Players/Suppliers Profiles and Sales Data

6.1 DANISCO

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Natamycin Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 DANISCO Natamycin Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 DSM

6.2.2 Natamycin Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 DSM Natamycin Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Vgp Pharmachem

6.3.2 Natamycin Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Vgp Pharmachem Natamycin Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Handary

6.4.2 Natamycin Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Handary Natamycin Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 AMTECH Biotech

6.5.2 Natamycin Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 AMTECH Biotech Natamycin Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Zhejiang Silver Elephant Bio-engineering

6.6.2 Natamycin Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Zhejiang Silver Elephant Bio-engineering Natamycin Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Lanzhou Weiri Bio-engineering

6.7.2 Natamycin Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Lanzhou Weiri Bio-engineering Natamycin Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 MEIHUA Group

6.8.2 Natamycin Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 MEIHUA Group Natamycin Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Zhengzhou New Frey Biotechnology

6.9.2 Natamycin Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Zhengzhou New Frey Biotechnology Natamycin Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Chihon Biotechnology

6.10.2 Natamycin Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Chihon Biotechnology Natamycin Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Jiaozuo Joincare Biotechnological

6.12 Beijing Oriental Rada Biotech

6.13 Pucheng Lifecome Biochemistry

7 Natamycin Manufacturing Cost Analysis

7.1 Natamycin Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Natamycin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Natamycin Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Natamycin Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Natamycin Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Natamycin Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Natamycin Sales Volume Forecast by Type (2017-2022)

11.3 United States Natamycin Sales Volume Forecast by Application (2017-2022)

11.4 United States Natamycin Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Natamycin

Figure United States Natamycin Market Size (K MT) by Type (2012-2022)

Figure United States Natamycin Sales Volume Market Share by Type (Product Category) in 2016

Figure Natamycin 50% Product Picture

Figure Natamycin 95% Product Picture

Figure United States Natamycin Market Size (K MT) by Application (2012-2022)

Figure United States Sales Market Share of Natamycin by Application in 2016

Figure Food Industry Examples

Table Key Downstream Customer in Food Industry

Figure Medical Industry Examples

Table Key Downstream Customer in Medical Industry

Figure Other Examples

Table Key Downstream Customer in Other

Figure United States Natamycin Market Size (Million USD) by Region (2012-2022)

Figure The West Natamycin Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Natamycin Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Natamycin Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Natamycin Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Natamycin Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Natamycin Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Natamycin Sales (K MT) and Growth Rate (2012-2022)

Figure United States Natamycin Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Natamycin Market Major Players Product Sales Volume (K MT) (2012-2017)

Table United States Natamycin Sales (K MT) of Key Players/Suppliers (2012-2017)

Table United States Natamycin Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Natamycin Sales Share by Players/Suppliers

Figure 2017 United States Natamycin Sales Share by Players/Suppliers

Figure United States Natamycin Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Natamycin Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Natamycin Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Natamycin Revenue Share by Players/Suppliers

Figure 2017 United States Natamycin Revenue Share by Players/Suppliers

Table United States Market Natamycin Average Price (USD/MT) of Key Players/Suppliers (2012-2017)

Figure United States Market Natamycin Average Price (USD/MT) of Key Players/Suppliers in 2016

Figure United States Natamycin Market Share of Top 3 Players/Suppliers

Figure United States Natamycin Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Natamycin Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Natamycin Product Category

Table United States Natamycin Sales (K MT) by Region (2012-2017)

Table United States Natamycin Sales Share by Region (2012-2017)

Figure United States Natamycin Sales Share by Region (2012-2017)

Figure United States Natamycin Sales Market Share by Region in 2016

Table United States Natamycin Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Natamycin Revenue Share by Region (2012-2017)

Figure United States Natamycin Revenue Market Share by Region (2012-2017)

Figure United States Natamycin Revenue Market Share by Region in 2016

Table United States Natamycin Price (USD/MT) by Region (2012-2017)

Table United States Natamycin Sales (K MT) by Type (2012-2017)

Table United States Natamycin Sales Share by Type (2012-2017)

Figure United States Natamycin Sales Share by Type (2012-2017)

Figure United States Natamycin Sales Market Share by Type in 2016

Table United States Natamycin Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Natamycin Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Natamycin by Type (2012-2017)

Figure Revenue Market Share of Natamycin by Type in 2016

Table United States Natamycin Price (USD/MT) by Types (2012-2017)

Figure United States Natamycin Sales Growth Rate by Type (2012-2017)

Table United States Natamycin Sales (K MT) by Application (2012-2017)

Table United States Natamycin Sales Market Share by Application (2012-2017)

Figure United States Natamycin Sales Market Share by Application (2012-2017)

Figure United States Natamycin Sales Market Share by Application in 2016

Table United States Natamycin Sales Growth Rate by Application (2012-2017)

Figure United States Natamycin Sales Growth Rate by Application (2012-2017)

Table DANISCO Basic Information List

Table DANISCO Natamycin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure DANISCO Natamycin Sales Growth Rate (2012-2017)

Figure DANISCO Natamycin Sales Market Share in United States (2012-2017)

Figure DANISCO Natamycin Revenue Market Share in United States (2012-2017)

Table DSM Basic Information List

Table DSM Natamycin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure DSM Natamycin Sales Growth Rate (2012-2017)

Figure DSM Natamycin Sales Market Share in United States (2012-2017)

Figure DSM Natamycin Revenue Market Share in United States (2012-2017)

Table Vgp Pharmachem Basic Information List

Table Vgp Pharmachem Natamycin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Vgp Pharmachem Natamycin Sales Growth Rate (2012-2017)

Figure Vgp Pharmachem Natamycin Sales Market Share in United States (2012-2017)

Figure Vgp Pharmachem Natamycin Revenue Market Share in United States (2012-2017)

Table Handary Basic Information List

Table Handary Natamycin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Handary Natamycin Sales Growth Rate (2012-2017)

Figure Handary Natamycin Sales Market Share in United States (2012-2017)

Figure Handary Natamycin Revenue Market Share in United States (2012-2017)

Table AMTECH Biotech Basic Information List

Table AMTECH Biotech Natamycin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure AMTECH Biotech Natamycin Sales Growth Rate (2012-2017)

Figure AMTECH Biotech Natamycin Sales Market Share in United States (2012-2017)

Figure AMTECH Biotech Natamycin Revenue Market Share in United States (2012-2017)

Table Zhejiang Silver Elephant Bio-engineering Basic Information List

Table Zhejiang Silver Elephant Bio-engineering Natamycin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Zhejiang Silver Elephant Bio-engineering Natamycin Sales Growth Rate (2012-2017)

Figure Zhejiang Silver Elephant Bio-engineering Natamycin Sales Market Share in United States (2012-2017)

Figure Zhejiang Silver Elephant Bio-engineering Natamycin Revenue Market Share in United States (2012-2017)

Table Lanzhou Weiri Bio-engineering Basic Information List

Table Lanzhou Weiri Bio-engineering Natamycin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Lanzhou Weiri Bio-engineering Natamycin Sales Growth Rate (2012-2017)

Figure Lanzhou Weiri Bio-engineering Natamycin Sales Market Share in United States (2012-2017)

Figure Lanzhou Weiri Bio-engineering Natamycin Revenue Market Share in United States (2012-2017)

Table MEIHUA Group Basic Information List

Table MEIHUA Group Natamycin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure MEIHUA Group Natamycin Sales Growth Rate (2012-2017)

Figure MEIHUA Group Natamycin Sales Market Share in United States (2012-2017)

Figure MEIHUA Group Natamycin Revenue Market Share in United States (2012-2017)

Table Zhengzhou New Frey Biotechnology Basic Information List

Table Zhengzhou New Frey Biotechnology Natamycin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Zhengzhou New Frey Biotechnology Natamycin Sales Growth Rate (2012-2017)

Figure Zhengzhou New Frey Biotechnology Natamycin Sales Market Share in United States (2012-2017)

Figure Zhengzhou New Frey Biotechnology Natamycin Revenue Market Share in United States (2012-2017)

Table Chihon Biotechnology Basic Information List

Table Chihon Biotechnology Natamycin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Chihon Biotechnology Natamycin Sales Growth Rate (2012-2017)

Figure Chihon Biotechnology Natamycin Sales Market Share in United States (2012-2017)

Figure Chihon Biotechnology Natamycin Revenue Market Share in United States (2012-2017)

Table Jiaozuo Joincare Biotechnological Basic Information List

Table Beijing Oriental Rada Biotech Basic Information List

Table Pucheng Lifecome Biochemistry Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Natamycin

Figure Manufacturing Process Analysis of Natamycin

Figure Natamycin Industrial Chain Analysis

Table Raw Materials Sources of Natamycin Major Players/Suppliers in 2016

Table Major Buyers of Natamycin

Table Distributors/Traders List

Figure United States Natamycin Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure United States Natamycin Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Natamycin Price (USD/MT) Trend Forecast (2017-2022)

Table United States Natamycin Sales Volume (K MT) Forecast by Type (2017-2022)

Figure United States Natamycin Sales Volume (K MT) Forecast by Type (2017-2022)

Figure United States Natamycin Sales Volume (K MT) Forecast by Type in 2022

Table United States Natamycin Sales Volume (K MT) Forecast by Application (2017-2022)

Figure United States Natamycin Sales Volume (K MT) Forecast by Application (2017-2022)

Figure United States Natamycin Sales Volume (K MT) Forecast by Application in 2022

Table United States Natamycin Sales Volume (K MT) Forecast by Region (2017-2022)

Table United States Natamycin Sales Volume Share Forecast by Region (2017-2022)

Figure United States Natamycin Sales Volume Share Forecast by Region (2017-2022)

Figure United States Natamycin Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources